S-217622, a 3CL Protease Inhibitor and Clinical Candidate for SARSCoV-2

Tyndall, JDA

Tyndall, JDA (通讯作者),Univ Otago, Sch Pharm, Dunedin 9054, New Zealand.

JOURNAL OF MEDICINAL CHEMISTRY, 2022; 65 (9): 6496